Publication:
Pembrolizumab vs Placebo for Early-Stage Non.small-Cell Lung Cancer After Resection and Adjuvant Therapy: Subgroup Analysis of Patients Who Received Adjuvant Chemotherapy in the Phase 3 PEARLS/KEYNOTE-091 Study

Simple item page
dc.authorwosidEruzun, Hasan/Kod-7808-2024
dc.contributor.authorAlibakan, Ozlem Kandemir
dc.contributor.authorEruzun, Hasan
dc.contributor.authorGokden, Yasemin
dc.contributor.authorArman, Yucel
dc.contributor.authorTukek, Tufan
dc.date.accessioned2025-12-11T00:38:00Z
dc.date.issued2023
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Alibakan, Ozlem Kandemir; Arman, Yucel] Prof Dr Cemil Tascioglu City Hosp, Internal Med, Istanbul, Turkiye; [Eruzun, Hasan] Ondokuz Mayis Univ, Sch Med, Gastroenterol, Samsun, Turkiye; [Gokden, Yasemin] Prof Dr Cemil Tascioglu City Hosp, Gastroenterol, Istanbul, Turkiye; [Tukek, Tufan] Istanbul Univ, Sch Med, Internal Med, Istanbul, Turkiyeen_US
dc.description.woscitationindexScience Citation Index Expanded - Conference Proceedings Citation Index - Science
dc.identifier.endpageS279en_US
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.scopusqualityQ1
dc.identifier.startpageS279en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/38062
dc.identifier.volume78en_US
dc.identifier.wosWOS:001037135100422
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofJournal of Hepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePembrolizumab vs Placebo for Early-Stage Non.small-Cell Lung Cancer After Resection and Adjuvant Therapy: Subgroup Analysis of Patients Who Received Adjuvant Chemotherapy in the Phase 3 PEARLS/KEYNOTE-091 Studyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu